Suppr超能文献

重组抗体表达 GS-CHO 细胞系无血清培养基的合理开发和补料分批工艺。

Rational development of a serum-free medium and fed-batch process for a GS-CHO cell line expressing recombinant antibody.

机构信息

School of Life Science, Northeast Agricultural University, Harbin, 150030, China.

出版信息

Cytotechnology. 2013 May;65(3):363-78. doi: 10.1007/s10616-012-9488-4. Epub 2012 Aug 21.

Abstract

A serum-free medium (CHO-SFM) together with a fed-batch process was developed for the cultivation of a recombinant GS-CHO cell line producing TNFR-Fc. According to the metabolic characteristics of GS-CHO cell, a basal medium was prepared by supplementing DMEM:F12:RPMI1640 (2:1:1) with amino acids, insulin, transferrin, Pluronic F68 and some other ingredients. Statistical optimization approaches based on Plackett-Burman and central composite designs were then adopted to identify additional positive determinants and determine their optimal concentrations, which resulted in the final CHO-SFM medium formulations. The maximum antibody titer reached was 90.95 mg/l in the developed CHO-SFM, which was a 18 % and 10 fold higher than that observed in the commercial EX-CELL™ 302 medium (76.95 mg/l) and basal medium (8.28 mg/l), respectively. Subsequently, a reliable, reproducible and robust fed-batch strategy was designed according to the offline measurement of glucose, giving a final antibody yield of 378 mg/l, which was a threefold improvement over that in conventional batch culture (122 mg/l) using CHO-SFM. In conclusion, the use of design of experiment (DoE) method facilitated the development of CHO-SFM medium and fed-batch process for the production of recombinant antibody using GS-CHO cells.

摘要

开发了一种无血清培养基(CHO-SFM)和补料分批工艺,用于培养产生 TNFR-Fc 的重组 GS-CHO 细胞系。根据 GS-CHO 细胞的代谢特性,通过在 DMEM:F12:RPMI1640(2:1:1)中补充氨基酸、胰岛素、转铁蛋白、Pluronic F68 和其他一些成分来制备基础培养基。然后采用基于 Plackett-Burman 和中心复合设计的统计优化方法来确定其他积极决定因素并确定其最佳浓度,最终确定了 CHO-SFM 培养基配方。在开发的 CHO-SFM 中,抗体滴度最高达到 90.95mg/l,分别比商业 EX-CELL™302 培养基(76.95mg/l)和基础培养基(8.28mg/l)观察到的提高了 18%和 10 倍。随后,根据葡萄糖的离线测量设计了一种可靠、可重复和稳健的补料分批策略,最终抗体产量达到 378mg/l,比使用 CHO-SFM 的传统分批培养(122mg/l)提高了三倍。总之,使用实验设计(DoE)方法促进了 CHO-SFM 培养基和补料分批工艺的开发,用于生产 GS-CHO 细胞的重组抗体。

相似文献

引用本文的文献

5
Progress in fed-batch culture for recombinant protein production in CHO cells.补料分批培养 CHO 细胞生产重组蛋白的进展。
Appl Microbiol Biotechnol. 2023 Feb;107(4):1063-1075. doi: 10.1007/s00253-022-12342-x. Epub 2023 Jan 17.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验